Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clpd-Nk”

7 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 7 results

Testing effectiveness (Phase 2)Looking for participantsNCT06530576
What this trial is testing

Thalidomide for the Symptomatic Large Granular Lymphocytic Leukemia

Who this might be right for
T-LGL LeukemiaNK-LGL Leukemia
Institute of Hematology & Blood Diseases Hospital, China 48
Not applicableLooking for participantsNCT02863692
What this trial is testing

Registry of the German CLL Study Group

Who this might be right for
CLLSLLHCL+5 more
German CLL Study Group 8,000
Testing effectiveness (Phase 2)Looking for participantsNCT06716658
What this trial is testing

JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas

Who this might be right for
Lymphoma, T-CellNK-LGL LeukemiaT-LGL Leukemia+7 more
Institute of Hematology & Blood Diseases Hospital, China 48
Large-scale testing (Phase 3)UnknownNCT04453345
What this trial is testing

TPM Regimen (Thalidomide, Prednisone and Methotrexate) in LGLL

Who this might be right for
T-LGL LeukemiaClpd-Nk
Institute of Hematology & Blood Diseases Hospital, China 42
Not applicableLooking for participantsNCT07019766
What this trial is testing

National Longitudinal Cohort of Hematological Diseases-Large Granular Lymphocytic Leukemia

Who this might be right for
T-LGL LeukemiaNK-LGL Leukemia
Institute of Hematology & Blood Diseases Hospital, China 9,999
Testing effectiveness (Phase 2)Looking for participantsNCT06530550
What this trial is testing

PI3K Inhibitors for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas

Who this might be right for
Lymphoma, T-CellNK-LGL LeukemiaT-LGL Leukemia
Institute of Hematology & Blood Diseases Hospital, China 51
Not applicableLooking for participantsNCT05978141
What this trial is testing

A Registry for People With T-cell Lymphoma

Who this might be right for
T-cell LymphomaNK-Cell LymphomaT-cell Prolymphocytic Leukemia+28 more
Memorial Sloan Kettering Cancer Center 1,000